Friedrich-Schiller University
Jena, Thuringia, 07743, Germany
NCT Number: NCT04717076
The PrevA study is designed to evaluate our developed nutritional concept to implement a heart healthy diet. The nutritional concept based on nutrient-optimized daily menu plans for each study day. The plans are personalized according to participants age, gender, and level of physical activity. The PrevA study consists of four periods differing in the energy intake specified by the menu plans.
The study is carried out in a 4-armed parallel design. In group 1, the participants receive the individualized daily plans via the app coupled with the smartwatch to record participants physical activity and heart rate. Groups 2 and 3 receive a printed version of the daily plans with or without personal nutritional advice. The fourth group serves as a control group, which receives general nutritional recommendations but no daily menu plans. During this time, blood samples and urine are collected every four weeks to analyze the study parameters.
Looking for future studies?
Notify Me20 year–69 year
All sexes
Interventional
Not applicable
Jena, Thuringia, 07743, Germany
Smartphone-based communication technologies are developing rapidly, and the number of so-called mobile health applications is rising. The number of validated and scientifically tested offers is comparatively small. To address this weak point, we developed a personalized nutritional concept to implement a heart-healthy diet. In cooperation with the Preventicus GmbH, Jena, the concept was integrated in an App-based tool. In addition, the app relates to a smartwatch to encourage and track physical activity. The PrevA study will be conducted to evaluate the overall concept.
The nutritional concept based on nutrient-optimized daily menu plans for each study day. The plans are personalized according to participants age, gender, and level of physical activity.
The study is carried out in a 4-armed parallel design. In group 1, the participants receive the individualized daily plans via the app coupled with the smartwatch to record participants physical activity and heart rate. Groups 2 and 3 receive a printed version of the daily plans with or without personal nutritional advice. The fourth group serves as a control group, which receives general nutritional recommendations but no daily menu plans.
In groups 1 to 3, the daily plans are issued in 4 energy levels. At the beginning, the test subjects receive daily plans according to the recommendations for energy intake of the German Nutrition Society (DGE), adapted to their age, gender, and activity level (level 1). After four study weeks, the energy content of the plans is reduced to 85% of the energy intake recommended by the DGE (level 2) and after further four weeks of the PrevA study the energy level is reduced to 70% of the energy intake recommended by the DGE (level 3). Level 4 serves as a stabilization phase and provides the energy content of level 1. The study period extends over a total of 16 study weeks. During this time, blood samples and urine are collected every four weeks to analyze the study parameters. In addition, anthropometric data, data on personal health status and cardiovascular risk profile are assessed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comorbidities:
The App-based nutritional concept based on menu plan, which are personalized according to participants age, gender, physical activity. The App is coupled with a Smartwatch to encourage and track physical activity over the study period.
Nutritional concept based on personalized menu plans and individual nutritional counselling every four weeks (4 times during the study)
Nutritional concept based on personalized menu plans
Time frame: change from baseline after 4, 8, 12, 16 weeks
Body weight (kg)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Body fat (%)
Time frame: change from baseline after 4, 8, 12, 16 weeks
systolic pressure (mm Hg)
Time frame: change from baseline after 4, 8, 12, 16 weeks
diastolic blood pressure (mm Hg)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Basal metabolic rate (kcal per day) - measurement: indirect calorimetry
Time frame: change from baseline after 4, 8, 12, 16 weeks
Total cholesterol (mmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
LDL cholesterol (mmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
HDL cholesterol (mmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Triacylglycerides (mmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Glucose (mmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Insulin (mU/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
HbA1c (%)
Time frame: change from baseline after 4, 8, 12, 16 weeks
alpha prothrombin time (s)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Fibrinogen (g/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
High sensitive c-reactive protein (mg/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Homocysteine (µmol/l)
Time frame: change from baseline after 16 weeks
Triiodothyronine fT3 (pmol/l)
Time frame: change from baseline after 16 weeks
Thyroxine fT4 (pmol/l)
Time frame: change from baseline after 16 weeks
Thyroid-stimulating hormone (mU/l)
Time frame: change from baseline after 16 weeks
Parathyroid hormone (ng/l)
Time frame: change from baseline after 16 weeks
Alkaline phosphatase (µg/l)
Time frame: change from baseline after 16 weeks
Osteocalcin (ng/ml)
Time frame: change from baseline after 16 weeks
Uric acid (µmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Alanine aminotransferase (µmol/l*s)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Aspartate transaminase (µmol/l*s)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Cholinesterase (µmol/l*s)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Gamma-glutamyltransferase (µmol/l*s)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Lactate dehydrogenase (µmol/l*s)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Fatty acid distribution in plasma lipids (% fatty acid methyl esters)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Fatty acid distribution in erythrocyte lipids (% fatty acid methyl esters)
Time frame: change from baseline after 16 weeks
Vitamin A (mmol/l)
Time frame: change from baseline after 16 weeks
Vitamin D (nmol/l)
Time frame: change from baseline after 16 weeks
Vitamin E (µmol/l)
Time frame: change from baseline after 16 weeks
Vitamin B1 (nmol/l)
Time frame: change from baseline after 16 weeks
Vitamin B2 (nmol/l)
Time frame: change from baseline after 16 weeks
Vitamin B6 (nmol/l)
Time frame: change from baseline after 16 weeks
Vitamin B12 (pmol/l)
Time frame: change from baseline after 16 weeks
Holo-transcobalamin (pmol/l)
Time frame: change from baseline after 16 weeks
Folic acid (µg/l)
Time frame: change from baseline after 16 weeks
Vitamin H (ng/l)
Time frame: change from baseline after 16 weeks
Vitamin C (mg/l)
Time frame: change from baseline after 16 weeks
Calcium (mmol/l)
Time frame: change from baseline after 16 weeks
Potassium (mmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Iron (µmol/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Ferritin (µg/l)
Time frame: change from baseline after 4, 8, 12, 16 weeks
Transferrin (g/l)
Time frame: change from baseline after 16 weeks
Iodine (µmol/l)
Time frame: change from baseline after 16 weeks
Selenium (µmol/l)
Time frame: change from baseline after 16 weeks
Zinc (µmol/l)
Time frame: change from baseline after 16 weeks
Creatinine (mmol/l)
Time frame: change from baseline after 16 weeks
Albumine (mg/l)
Time frame: change from baseline after 16 weeks
Selenium (µmol/24 h)
Time frame: change from baseline after 16 weeks
Zinc (µmol/24 h)
University of Jena
Other
PrevA Study - Evaluation of an App-based Nutritional Concept to Lower Cardiovascular Risk Factors (Focus: Weight Reduction)
Acronym: PrevA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00687115
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT05184361
Body Weight, Body Weight Changes
Cruz Quebrada, Lisbon District, Portugal
View Trial DetailsNCT07718516
Body Weight, Body Weight Changes
New York, United States
View Trial DetailsNCT04632810
Acid-Base Imbalance, Acidosis
Levanger, Norway
View Trial Details